These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10465535)

  • 21. Selective N-type neuronal voltage-sensitive calcium channel blocker, SNX-111, produces spinal antinociception in rat models of acute, persistent and neuropathic pain.
    Bowersox SS; Gadbois T; Singh T; Pettus M; Wang YX; Luther RR
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1243-9. PubMed ID: 8968347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuronal N-type calcium channel blockers: a series of 4-piperidinylaniline analogs with analgesic activity.
    Hu LY; Ryder TR; Rafferty MF; Siebers KM; Malone T; Chatterjee A; Feng MR; Lotarski SM; Rock DM; Stoehr SJ; Taylor CP; Weber ML; Miljanich GP; Millerman E; Szoke BG
    Drug Des Discov; 2000; 17(1):85-93. PubMed ID: 10928451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel series of pyrazolylpiperidine N-type calcium channel blockers.
    Subasinghe NL; Wall MJ; Winters MP; Qin N; Lubin ML; Finley MF; Brandt MR; Neeper MP; Schneider CR; Colburn RW; Flores CM; Sui Z
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4080-3. PubMed ID: 22608964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and biological evaluation of novel N3-substituted dihydropyrimidine derivatives as T-type calcium channel blockers and their efficacy as analgesics in mouse models of inflammatory pain.
    Teleb M; Zhang FX; Huang J; Gadotti VM; Farghaly AM; AboulWafa OM; Zamponi GW; Fahmy H
    Bioorg Med Chem; 2017 Mar; 25(6):1926-1938. PubMed ID: 28233679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Block of voltage-dependent calcium channels by aliphatic monoamines.
    Beedle AM; Zamponi GW
    Biophys J; 2000 Jul; 79(1):260-70. PubMed ID: 10866952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons.
    Yagami T; Ueda K; Asakura K; Nakazato H; Hata S; Kuroda T; Sakaeda T; Sakaguchi G; Itoh N; Hashimoto Y; Hori Y
    J Neurochem; 2003 May; 85(3):749-58. PubMed ID: 12694401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of evoked peptide release by voltage-sensitive calcium channels in rat sensory neurons.
    Evans AR; Nicol GD; Vasko MR
    Brain Res; 1996 Mar; 712(2):265-73. PubMed ID: 8814901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockers.
    Renneberg D; Hubler F; Rey M; Hess P; Delahaye S; Gatfield J; Iglarz M; Hilpert K
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3941-6. PubMed ID: 26231163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of voltage-sensitive calcium channels by the A2A adenosine receptor in PC12 cells.
    Park TJ; Chung S; Han MK; Kim UH; Kim KT
    J Neurochem; 1998 Sep; 71(3):1251-60. PubMed ID: 9721751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and SAR of novel 2-arylthiazolidinones as selective analgesic N-type calcium channel blockers.
    Knutsen LJ; Hobbs CJ; Earnshaw CG; Fiumana A; Gilbert J; Mellor SL; Radford F; Smith NJ; Birch PJ; Russell Burley J; Ward SD; James IF
    Bioorg Med Chem Lett; 2007 Feb; 17(3):662-7. PubMed ID: 17134896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channels.
    Mortell KH; Anderson DJ; Lynch JJ; Nelson SL; Sarris K; McDonald H; Sabet R; Baker S; Honore P; Lee CH; Jarvis MF; Gopalakrishnan M
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1138-41. PubMed ID: 16380257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and SAR studies of a novel series of T-type calcium channel blockers.
    Park SJ; Park SJ; Lee MJ; Rhim H; Kim Y; Lee JH; Chung BY; Lee JY
    Bioorg Med Chem; 2006 May; 14(10):3502-11. PubMed ID: 16434203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure-activity relationships of omega-conotoxins at N-type voltage-sensitive calcium channels.
    Nielsen KJ; Schroeder T; Lewis R
    J Mol Recognit; 2000; 13(2):55-70. PubMed ID: 10822250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new omega-conotoxin that targets N-type voltage-sensitive calcium channels with unusual specificity.
    Favreau P; Gilles N; Lamthanh H; Bournaud R; Shimahara T; Bouet F; Laboute P; Letourneux Y; Ménez A; Molgó J; Le Gall F
    Biochemistry; 2001 Dec; 40(48):14567-75. PubMed ID: 11724570
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Cysteine based N-type calcium channel blockers: structure-activity relationships of the C-terminal lipophilic moiety, and oral analgesic efficacy in rat pain models.
    Seko T; Kato M; Kohno H; Ono S; Hashimura K; Takenobu Y; Takimizu H; Nakai K; Maegawa H; Katsube N; Toda M
    Bioorg Med Chem Lett; 2002 Sep; 12(17):2267-9. PubMed ID: 12161113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship study and discovery of indazole 3-carboxamides as calcium-release activated calcium channel blockers.
    Bai S; Nagai M; Koerner SK; Veves A; Sun L
    Bioorg Med Chem Lett; 2017 Feb; 27(3):393-397. PubMed ID: 28057422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Calcium channel as molecular target of drug action].
    Taglialatela M; Annunziato L; Marino A
    Clin Ter; 1989 Dec; 131(5):299-305. PubMed ID: 2558001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The conditions of Ca2+ entry via L-type channels for induction of serotonin release from rabbit hippocampus.
    Feuerstein TJ; Neuschwander E; Sauermann W; Lupp A
    Eur J Pharmacol; 1991 May; 198(1):37-42. PubMed ID: 1717292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peptides targeting voltage-gated calcium channels.
    Norton RS; McDonough SI
    Curr Pharm Des; 2008; 14(24):2480-91. PubMed ID: 18781996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.